Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Arrowhead Pharmaceuticals, Inc.
arrowheadpharmaceuticals.comAI Executive Summary
AI-powered analysis of 8-K filing content
Arrowhead Pharmaceuticals held its 2026 Annual Meeting of Stockholders on March 19, 2026, where shareholders elected seven directors, approved executive compensation, authorized an amended incentive plan, and ratified KPMG LLP as auditors. This routine governance event demonstrates strong shareholder engagement with 119.8 million shares represented.
Key Takeaways
Seven directors were elected to the Board of Directors, indicating stable corporate governance
Shareholders approved executive compensation in a non-binding advisory vote, showing alignment on pay practices
3 more takeaways